Mission

To develop precision medicines that target hypoxic (low oxygen) areas in tumours that conventional chemotherapy, immunotherapy and radiotherapy do not treat. Hypoxia is recognized as a key resistance factor affecting all cancer treatments

GET IN TOUCH

COMPANY DETAILS

OncoTherics

Poland
OncoTherics Poland Spółka Akcyjna
ul. prof. Michała Bobrzyńskiego 14
30-348 Kraków
Poland

 

Contact

OncoTherics Poland Spółka Akcyjna
ul. prof. Michała Bobrzyńskiego 14
30-348 Kraków
Poland

Copyright © 2010 - 2020 All rights reserved